Prognostic Value of Hyperglycemia on Admission on In-hospital Outcomes in Patients Presenting with ST-elevation Myocardial Infarction

被引:10
|
作者
Shahid, Muhammad [1 ]
Zarif, Hafiz Muhammad Asif [1 ]
Farid, Muhammad Shahzad [1 ]
Abid, Muhammad Shoaib [1 ]
Akhtar, Burhan [1 ]
Khan, Momin Rasheed [1 ]
机构
[1] Ch Pervaiz Elahi Inst Cardiol, Cardiol, Multan, Pakistan
关键词
acute st-elevation myocardial infarction; hyperglycemia; in-hospital mortality; MORTALITY; IMPACT; PLATELET;
D O I
10.7759/cureus.7024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Type 2 diabetes mellitus (T2DM) is associated with acute coronary syndrome, and elevated blood glucose levels on hospital admission may influence outcomes in patients with ST-elevated myocardial infarction (STEMI). We conducted this study to determine the prognostic outcome of hyperglycemia at admission on in-hospital outcomes of STEMI patients with and without T2DM. Methods This prospective study was conducted from June 13, 2018, to October 12, 2019, and included patients older than 18 years diagnosed with STEMI. For our purposes, hyperglycemia was defined as blood glucose levels >140 mg/dl. Hypertension was considered as systolic blood pressure >140 mmHg or diastolic pressure > 90 mmHg. The predictive value of glycemia on admission for outcomes was assessed via patient mortality following thrombolysis or percutaneous coronary intervention (PCI). Results Our study included 256 patients (196 men, 76.5%; 60 women, 23.5%) with a mean age of 55 +/- 11 years. A total of 92 patients (35.9%) were admitted with known T2DM diagnoses: 72 of them had hyperglycemia and 20 patients had euglycemia (p = 0.0001). Post-PCI mortality was six (18.8%) in the hyperglycemic group and one (2.2%) in the euglycemic group (p = 0.03). Inhospital mortality was higher in the hyperglycemic group (n = 12, 12.5%) compared to the euglycemic group ( n = 6, 3.7%; p = 0.015). Significant risk factors of mortality for STEMI patients with hyperglycemia on admission were age 60 years or older (odds ratio [OR], 5.63 [1.54-20.58]; p = 0.007), heart failure on admission (OR, 6.84 [1.85-25.22)]; p = 0.003), T2DM (OR, 4.14 [0.50-33.96]; p = 0.05), and presenting with renal failure (OR, 6.78 [1.74-26.42]; p = 0.009). Conclusion Thrombolysis and PCI are effective and safe treatments in STEMI patients. Hyperglycemia has a great adverse impact on hospital outcomes in patients with or without T2DM. STEMI patients with hyperglycemia on hospital admission have higher mortality rates.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Arrhythmias and in-hospital mortality of ST-elevation myocardial infarction patients in Moewardi General Hospital Surakarta
    Perkasa, I.
    Paramita, D. A.
    Sulistyono, T.
    Wasyanto, T.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2017, 19 (0E) : E40 - E40
  • [42] Beta-blockers attenuate ST-elevation in patients presenting with ST-elevation myocardial infarction
    Leite, S. M.
    Rodrigues, J.
    Sousa, C.
    Vasconcelos, M.
    Goncalves, A.
    Martins, E.
    Amorim, S.
    Silva Cardoso, J.
    Campelo, M.
    Julia Maciel, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S93 - S93
  • [43] ASSOCIATION OF HOSPITAL TEACHING STATUS WITH IN-HOSPITAL MORTALITY OF ST-ELEVATION MYOCARDIAL INFARCTION
    Gupta, Tanush
    Kolte, Dhaval
    Khera, Sahil
    Harikrishnan, Prakash
    Mujib, Marjan
    Aronow, Wilbert
    Jain, Diwakar
    Frishman, William
    Sule, Sachin
    Cooper, Howard
    Bhatt, Deepak
    Fonarow, Gregg
    Panza, Julio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 575 - 575
  • [44] Pre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarction
    McCaul, Michael
    Lourens, Andrit
    Kredo, Tamara
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (09):
  • [45] Prognostic value of combined myocardial performance index in patients with acute ST-elevation myocardial infarction
    Hayrapetyan, H. G.
    Petrosyan, H. H.
    Kristosturyan, A. A.
    Tavaratsyan, A. R.
    Hayrapetyan, L. H.
    Kalantaryan, V. A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [46] Myocarditis Presenting as ST-Elevation Myocardial Infarction
    Hussain, Fahad
    Moazez, Carmel
    Allen, Kathleen
    Hsu, Pamela
    Welch, Kathryn
    Febbo, Jennifer
    Rehman, Mueez
    Garcia, Mark
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [47] Reperfusion Times and Outcomes in Patients With ST-Elevation Myocardial Infarction Presenting Without Pre-Hospital Notification
    Hamilton, Garry W.
    Yeoh, Julian
    Dinh, Diem
    Brennan, Angela
    Yudi, Matias B.
    Freeman, Melanie
    Horrigan, Mark
    Martin, Lorelle
    Reid, Christopher M.
    Yip, Thomas
    Picardo, Sandra
    Sharma, Anand
    Duffy, Stephen J.
    Farouque, Omar
    Clark, David J.
    Ajani, Andrew E.
    Melbourne Interventional Grp, Melbourne Interventional Group
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 41 : 136 - 141
  • [48] Prognostic value of B-type natriuretic peptide levels on admission in patients with acute ST-elevation myocardial infarction
    Grabowski, M
    Filipiak, K
    Karpinski, G
    Wretowski, D
    Rdzanek, A
    Rudzki, D
    Glowczynska, R
    Opolski, G
    EUROPEAN HEART JOURNAL, 2003, 24 : 79 - 79
  • [49] In-hospital left ventricular thrombus following ST-elevation myocardial infarction
    Albaeni, Aiham
    Chatila, Khaled
    Beydounc, Hind A.
    Beydoun, May A.
    Morsy, Mohammad
    Khalife, Wissam I.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 299 : 1 - 6
  • [50] Metabolic Syndrome and Acute ST-Elevation Myocardial Infarction: In-Hospital Outcome
    Momen, Abdul
    Ali, Mahboob
    CIRCULATION, 2010, 122 (02) : E368 - E368